Phase I trial of an embryonic stem cell-based treatment for amyotrophic lateral sclerosis.
Phase of Trial: Phase I/II
Latest Information Update: 21 Jun 2017
At a glance
- Drugs Stem cell therapies (Primary)
- Indications Amyotrophic lateral sclerosis
- Focus Adverse reactions
- Sponsors Kadimastem
- 21 Jun 2017 According to a Kadimastem media release, company recieved approval from the IRB (Helsinki Committee) of the Hadassah Ein Kerem Hospital for this study.
- 15 Oct 2014 New trial record